Integrating Interventional Cardiology and Heart Failure Management for Cardiogenic Shock

Navin K Kapur1, Carlos D Davila1, Marwan F Jumean2

  • 1The Acute Mechanical Support Working Group, The Cardiovascular Center, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA.

Insights

Cardiogenic shock, a common cause of in-hospital death, is increasingly complex. Percutaneous acute mechanical circulatory support (AMCS) offers improved outcomes for these high-risk patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Heart Failure Management

Background:

  • Cardiogenic shock is a leading cause of in-hospital mortality.
  • Increasing patient complexity, particularly with acute myocardial infarction, complicates cardiogenic shock management.
  • Percutaneous acute mechanical circulatory support (AMCS) use has risen significantly over the last decade.

Purpose of the Study:

  • To review current guidelines and consensus statements on AMCS for cardiogenic shock.
  • To highlight the evolving role of interventional heart failure specialists.
  • To emphasize the integration of advanced hemodynamic and catheter-based therapies.

Main Methods:

  • Review of recent data and existing literature on cardiogenic shock and AMCS.
  • Analysis of emerging guidelines and consensus statements.
  • Discussion of the interdisciplinary heart team approach.

Main Results:

  • Guidelines are emerging for patient selection, timing, device choice, and post-implantation care for AMCS.
  • Interventional heart failure specialists are crucial in managing complex hemodynamic and catheter-based therapies.
  • The focus is on improving patient outcomes through integrated care.

Conclusions:

  • Optimizing patient selection and management strategies for AMCS is critical.
  • The expertise of interventional heart failure specialists is essential for successful AMCS implementation.
  • Advanced hemodynamic and catheter-based therapies are key to improving outcomes in cardiogenic shock.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
474
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
551
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
347
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
428
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
673
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K